share_log

Teladoc Health | 10-Q: Q2 2024 Earnings Report

Teladoc Health | 10-Q: Q2 2024 Earnings Report

Teladoc Health | 10-Q：2024财年二季报
美股SEC公告 ·  2024/08/01 22:26

Moomoo AI 已提取核心信息

Teladoc Health reported Q2 2024 revenue of $642.4 million, down 2% year-over-year, with a net loss of $837.7 million primarily due to a $790 million non-cash goodwill impairment charge related to its BetterHelp segment. The Integrated Care segment revenue grew 5% to $377.4 million, while BetterHelp revenue declined 9% to $265.0 million with a 14% decrease in average monthly paying users.Adjusted EBITDA increased 24% to $89.5 million, with Integrated Care segment Adjusted EBITDA growing 69% to $64.0 million on higher gross profit and lower operating expenses. BetterHelp segment Adjusted EBITDA decreased 26% to $25.5 million. The company maintained a strong liquidity position with $1.16 billion in cash and cash equivalents as of June 30, 2024.The company's U.S. Integrated Care membership grew 8% year-over-year to 92.4 million members, while chronic care program enrollment increased 9% to 1.17 million. Management continues to focus on operational efficiency, with cost reductions across multiple expense categories including technology, marketing, and general administrative expenses.
Teladoc Health reported Q2 2024 revenue of $642.4 million, down 2% year-over-year, with a net loss of $837.7 million primarily due to a $790 million non-cash goodwill impairment charge related to its BetterHelp segment. The Integrated Care segment revenue grew 5% to $377.4 million, while BetterHelp revenue declined 9% to $265.0 million with a 14% decrease in average monthly paying users.Adjusted EBITDA increased 24% to $89.5 million, with Integrated Care segment Adjusted EBITDA growing 69% to $64.0 million on higher gross profit and lower operating expenses. BetterHelp segment Adjusted EBITDA decreased 26% to $25.5 million. The company maintained a strong liquidity position with $1.16 billion in cash and cash equivalents as of June 30, 2024.The company's U.S. Integrated Care membership grew 8% year-over-year to 92.4 million members, while chronic care program enrollment increased 9% to 1.17 million. Management continues to focus on operational efficiency, with cost reductions across multiple expense categories including technology, marketing, and general administrative expenses.
Teladoc Health报告2024年第二季度营业收入为64240万美元，同比下降2%，净亏损为83770万美元，主要由于其BetterHelp部门的79000万美元非现金商誉减值费用。综合护理部门的营业收入增长5%，达到37740万美元，而BetterHelp的营业收入下降9%，为26500万美元，平均每月付费用户数减少14%。调整后的EBITDA增加24%，达到8950万美元，综合护理部门的调整后EBITDA增长69%，达到6400万美元，得益于毛利润提高和营业费用降低。BetterHelp部门的调整后EBITDA下降26%，为2550万美元。截至2024年6月30日，公司保持强劲的流动性，现金及现金等价物达到11.6亿美元。公司在美国的综合护理会员同比增长8%，达9240万名会员，而慢性病护理项目的注册人数增加9%，达117万。管理层继续关注运营效率，各类费用的成本减少，包括科技、市场营销和一般管理费用。
Teladoc Health报告2024年第二季度营业收入为64240万美元，同比下降2%，净亏损为83770万美元，主要由于其BetterHelp部门的79000万美元非现金商誉减值费用。综合护理部门的营业收入增长5%，达到37740万美元，而BetterHelp的营业收入下降9%，为26500万美元，平均每月付费用户数减少14%。调整后的EBITDA增加24%，达到8950万美元，综合护理部门的调整后EBITDA增长69%，达到6400万美元，得益于毛利润提高和营业费用降低。BetterHelp部门的调整后EBITDA下降26%，为2550万美元。截至2024年6月30日，公司保持强劲的流动性，现金及现金等价物达到11.6亿美元。公司在美国的综合护理会员同比增长8%，达9240万名会员，而慢性病护理项目的注册人数增加9%，达117万。管理层继续关注运营效率，各类费用的成本减少，包括科技、市场营销和一般管理费用。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Performant Healthcare
    PHLT
    -- 3.000
    SHL Telemedicine
    SHLT
    -- 1.950
    Simulations Plus
    SLP
    -- 24.290
    Mangoceuticals
    MGRX
    -- 2.380
    Forian
    FORA
    -- 2.000
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股财报季火热：惊喜盈利能否延续涨势？
    1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？ 展开
    中国两会：会议前后股票价格走势的主要要点